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Abstract
 
Type-B T cells raised against the immunodominant peptide in hen egg lysozyme (HEL
 
48–62
 
)
do not respond to whole lysozyme, and this has been thought to indicate that peptide can bind
to l-A
 
k
 
 in different conformations. Here we demonstrate that such T cells recognize a deami-
dated form of the HEL peptide and not the native peptide. The sequence of the HEL epitope
facilitates rapid and spontaneous deamidation when present as a free peptide or within a flexi-
ble domain. However, this deamidated epitope is not created within intact lysozyme, most
likely because it resides in a highly structured part of the protein. These findings argue against
the existence of multiple conformations of the same peptide–MHC complex and have impor-
tant implications for the design of peptide-based vaccines. Furthermore, as the type-B T cells
are known to selectively evade induction of tolerance when HEL is expressed as a transgene,
these results suggest that recognition of posttranslationally modified self-antigen may play a
role in autoimmunity.
Key words: posttranslational/chemical modiﬁcation • autoimmunity • peptide • deamidation • 
T cell
 
Introduction
 
MHC class I and class II molecules have evolved to bind
short peptides and present them at the cell surface to circulat-
ing T lymphocytes. Recognition of these peptides by the
TCR can be exquisitely specific, such that minor changes in
the peptide–MHC complex structure can radically affect T
cell activation. Much of our understanding of the interac-
tions between peptide, MHC, and TCR comes from the
study of the immunodominant epitope of hen egg lysozyme
restricted by I-A
 
k
 
 (HEL
 
48–62
 
).
 
1
 
 Interestingly, the majority of
peptide-specific T cells isolated from mice that have been
immunized with this peptide fragment do not recognize
APC incubated with whole lysozyme (type-B T cells) (1, 2).
This is in contrast to the HEL
 
48–62
 
-specific T cells isolated
from mice immunized with HEL, all of which respond to
both peptide and whole antigen (type-A T cells) (1–3). The
type-B T cells also fail to respond to APCs engineered to ex-
press HEL in the vesicular compartment or to APCs that ex-
press the HEL
 
48–62
 
 peptide covalently linked to I-A
 
k
 
. How-
ever, as the type-B cells recognize APCs incubated with
trypsin-digested HEL (2), it is clear that these cells do not
simply recognize impurities present within the synthetic
peptide immunogen (4). Detailed analysis of the HEL
 
48–62
 
peptide binding to I-A
 
k
 
 demonstrated a critical requirement
for Asp-52 to bind in the P1 pocket of this class II molecule
(5, 6), ruling out the possibility that the type-A and type-B T
cells recognize the HEL peptide bound in different registers
to I-A
 
k
 
. Instead, Unanue and colleagues (1, 7) have proposed
that the HEL peptide could bind to I-A
 
k
 
 in at least two stable
conformations. According to this hypothesis, the type-A
conformation should be generated by the endogenous pro-
cessing of HEL to peptide and subsequent intracellular load-
ing on to I-A
 
k
 
, while peptides binding directly to I-A
 
k
 
 at the
cell surface were proposed to generate both type-B and
type-A conformers.
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Abbreviations used in this paper: 
 
ESI, electrospray ionization; FTICR-MS,
Fourier transform ion cyclotron resonance mass spectrometry; HEL, hen
egg lysozyme. 
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An alternative explanation could be that the two popu-
lations of T cells recognize structurally distinct peptides
that result from a spontaneous modification. Indeed, it can
be predicted from the primary sequence of the HEL
 
48–62
 
epitope that the asparagine at residue 59 should spontane-
ously deamidate (8). This is particularly interesting because
crystallographic studies of the I-A
 
k
 
–HEL
 
48–62
 
 complex
have demonstrated that this residue, positioned at P8, is
solvent exposed and available for direct contact with the
TCR (9). This type of asparagine deamidation is the most
common nonenzymatic protein modification occurring
under physiological conditions (10, 11). The reaction pro-
ceeds via a succinimide intermediate to form isoaspartate
and aspartate, as well as small amounts of 
 
d
 
-aspartate and
 
d
 
-isoaspartate (for review see reference 12). The deamida-
tion of asparagine is strongly promoted when the C-flank-
ing residue is a glycine, serine, or histidine, and in the
HEL
 
48–62
 
 epitope the asparagine residue is proceeded by a
serine. The spontaneous deamidation of asparagine is also
influenced by pH, temperature, and the position of the
residue within a given protein (12). In fact, constraints im-
posed when an asparagine is situated within a highly struc-
tured region of a protein can override the sequence-spe-
cific influence of the C-flanking residue and dramatically
reduce the rate of deamidation (10, 13). Interestingly, bio-
chemical studies have found no evidence that this residue
deamidates within intact lysozyme, although evidence for
deamidation was found at other residues (10, 14, 15). The
Asn-59 is situated within a 
 
 
 
-stranded secondary structure
close to the active site of lysozyme, and it may well be pro-
tected from nonenzymatic deamidation unless it is present
as a synthetic or tryptic peptide fragment. We therefore
hypothesized that the type-B T cell hybridomas may re-
spond to a deamidated peptide that can be formed when
the epitope is present as a free peptide, but not when
present as a whole antigen.
 
Materials and Methods
 
Antigens.
 
Synthetic peptides were prepared by multiple solid-
phase peptide synthesis on a robotic system (Syro MultiSynTech)
using Fmoc/OtBu chemistry and 2-chlorotrityl resin (Senn
Chemicals AG). For coupling, 10 equivalents (eq) of diisopropyl-
carbodiimide, 5 eq of 1-hydroxybenzotriazole, and 5 eq of pro-
tected amino acids were used. Peptides were cleaved off the resin,
and side chains were deprotected with trifluoroacetic acid/triiso-
propylsilane/water (94:5:1) (16). Peptides were precipitated by
adding ice cold diethylether, washed three times with diethyl-
ether, and lyophilized from tert-butyl-alcohol/water (4:1). Iden-
tity of the peptides was confirmed by electrospray mass spectrom-
etry, and purity was analyzed by RP-HPLC. Peptides with
purities 
 
 
 
90% were purified by preparative RP-HLPC. The fol-
lowing peptides were synthesized: p48–61, DGSTDYGIL-
QINSR; p48–61/D59, DGSTDYGILQIDSR; P48–61/isoD59,
DGSTDYGILQI-isoD-SR; p48–62, DGSTDYGILQINSRW;
p48–62/D59, DGSTDYGILQIDSRW; and p48–62/T62, DG-
STDYGILQINSRT. Peptides were weighed, re-suspended in
water, aliquoted, dried under vacuum, and stored at 
 
 
 
80
 
 
 
C un-
til use.
 
HEL that was crystallized and dialysed three times was pur-
chased from Sigma-Aldrich (cat no. L-6876) and unless otherwise
stated was freshly weighed and resuspended in PBS before use.
The genes coding for the recombinant 
 
 
 
IgD–IgG3
 
HEL46–61
 
 and
 
 
 
IgD–IgG3
 
HEL46–61/59D
 
 antibodies (unpublished data), which con-
tain residues 46–61 from HEL inserted into the L3 loop in the
CH1 domain, were introduced into an expression vector using a
strategy similar to that described previously (17). After transfec-
tion of NSO cells, single G418-resistant colonies that expressed
the antibody were isolated and grown at high density in a
miniPERM bioreactor (Heraeus Instruments). Antibody was
used either as supernatant directly frozen after 17 h culture or as
purified protein. Antibody was purified at room temperature on a
protein L (Actigen) column, eluted with 0.1 M Gly–HCL, pH
2.7, neutralized, and dialyzed for several days against PBS and
then RPMI growth medium before freezing at 
 
 
 
20
 
 
 
C.
 
High Resolution Mass Spectrometry and Micro-HPLC.
 
Chem-
ical deamidation within asparagine side chains was demonstrated
by high resolution ESI-FTICR-MS (electrospray ionization Fou-
rier transform ion cyclotron resonance mass spectrometry) mea-
surements (4.7 Tesla APEX
 
TM
 
II-ESI/MALDI-FTICR Mass
Spectrometer, passively shielded; Bruker Daltonik). On a UNIX-
based Silicon Graphics O2 Workstation, the mass spectrometry
software XMASS version 5.0.7 (Bruker Daltonik) was used for
mass calculation, data acquisition, and processing. ESI was per-
formed in the positive mode with a grounded capillary sprayer
needle mounted 60
 
 
 
 off-axis. For coupling with micro-HPLC,
the spray was supported with nitrogen nebulizing gas at ambient
pressure and 50 psi. For working with direct infusion, no nebu-
lizer gas was used. The ESI source (Analytica of Branford) was
connected with the diode array detector of the HPLC system by
using a fused silica capillary (365 
 
 
 
m OD, 75 
 
 
 
m ID) without
splitting the solvent stream. For liquid chromatography FTICR-
MS coupling, an HP series 1100 HPLC (Hewlett Packard) and an
RP-C
 
18
 
 column (GROM-Sil 120 ODS-4 HE; 1 
 
 
 
 60 mm) was
used. The samples were eluted with 0.1% formic acid in water (a)
and 0.1% formic acid in acetonitrile (b) using a linear gradient (0–
30% b over 40 min), a flow rate of 50 
 
 
 
l/min, and monitoring at
214 nm. FTICR-MS detection took place by measuring se-
quenced experiments, which included four averaged scans with a
total scan time of 
 
 
 
3 s.
 
T Cell Hybridoma IL-2 Secretion Assays.
 
The T cell hybrid-
oma 3A9 was generated by Allen et al. using HEL as the immu-
nogen (18). The ALV-48 hybridoma was generated after immu-
nization with a peptide covering HEL
 
48–61
 
, and the DAV-21
hybridoma was generated using a peptide covering HEL
 
48–62
 
 (1).
APCs were the B cell lymphoma C3.F6 that has been engineered
to express I-A
 
k
 
 (19) or freshly isolated spleen cells from CBA
(Bomholtgaard) or B10.BR mice (Harlan UK Ltd.). All cell lines
and assays were cultured in DMEM supplemented with 5% inac-
tivated newborn calf serum, penicillin/streptomycin, and 0.01 M
2-ME. Secretion of IL-2 was used as a marker for T cell activa-
tion using the following protocol: peptides were added in dupli-
cate at the final concentration indicated to 96-well U-bottomed
plates containing 5 
 
  
 
10
 
4
 
 APCs/well in a total volume of 100
 
 
 
l. T cell hybridomas were then added either directly or after in-
cubation at 37
 
 
 
C for 1 h, followed by three washes in 200 
 
 
 
l of
DMEM plus 2% newborn calf serum. T cells were added at 5 
 
 
 
10
 
4
 
 cells per well to give a total volume of 200 
 
 
 
l. Supernatants
were collected after 16 h and quantified for IL-2 by time re-
solved fluorometry using DELFIA
 
®
 
 reagents (Wallac) and rat
anti–murine IL-2 antibodies (JES6–1A12 and biotinylated JES6–
5H4; PharMingen). All T cell assays were performed at least 
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three times, with results from a single representative experiment
presented.
 
Results
 
Type-B Hybridomas Preferentially Respond to Peptides Con-
taining a Modified Residue 59.
 
To investigate whether
type-B T cells preferentially recognize modified peptides,
we synthesized the HEL peptide with asparagine (p48–61
and p48–62), aspartate (p48–61/D59 and p48–62/D59), or
isoaspartate (p48–61/isoD59) at position 59 and compared
their ability to stimulate a type-A T cell hybridoma (3A9)
and two type-B T cell hybridomas (ALV-48 and DAV-21)
(Fig. 1, a–c). As expected, the type-A hybridoma re-
sponded well to a B lymphoma cell line expressing I-A
 
k
 
(C3.F6) when either whole HEL or the native peptide was
added to the assay. No detectable response to synthetic
peptides containing aspartate or isoaspartate at residue 59
was made by 3A9.
The ALV-48 hybridomas gave a typical type-B profile
by responding to native peptide but not whole HEL.
However, in contrast to the lack of recognition of the
modified peptides by the type-A hybridoma, ALV-48 was
between two and three logs more sensitive to the 48–61/
59D peptide than the native peptide. ALV-48 also gave a
response to the peptide containing an isoaspartate at posi-
tion 59 that was comparable to the response to the native
peptide. Although initial experiments testing the DAV-21
hybridoma clearly showed preferential recognition of the
48–61/59D peptide over the native peptide, the responses
to both peptides were weak, and the superior recognition
of the deamidated peptide was not as pronounced as for the
ALV-48 T cell. As this hybridoma was raised against the
HEL
 
48–62
 
 peptide rather than the HEL
 
48–61
 
 peptide used to
generate ALV-48 (1), we suspected that this hybridoma re-
quired the additional tryptophan residue at the COOH ter-
minus for optimal recognition. Indeed, this was found to
be the case (Fig. 1 c). Moreover, the pattern of recognition
of the modified peptides was now similar to the response of
ALV-48, indicating that the DAV-21 also preferentially
recognized peptides with aspartate at residue 59 (Fig. 1 c).
We found no evidence for the recognition of peptides con-
taining isoaspartate at residue 59 by DAV-21.
 
The HEL
 
48–61
 
 Peptide Undergoes Rapid and Spontaneous
Deamidation.
 
The type-B T cell response to both the na-
tive and aspartate-containing peptides could be due to truly
cross-reactive TCRs, or, alternatively, to deamidation of
the native peptide during the course of the assay. As there is
a charge difference between asparagine and aspartate, and as
residue 59 is known to be a major TCR contact residue
within this epitope, we thought it unlikely that the T cells
were cross-reactive. We therefore analyzed the native pep-
tide for spontaneous deamidation by incubating the peptide
at 37
 
 
 
C in PBS, pH 7.5, and analyzing it by micro-HPLC-
FTICR mass spectrometry. The native and deamidated
peptide differs by only a single dalton, which can lead to
the monoisotopic signal from the deamidated peptide being
overlooked due to the first isotopic signal of the native spe-
cies. While the very high mass resolution provided by FT-
ICR-MS can discriminate between these signals, we chose
to couple FTICR-MS to micro-HPLC so that very small
amounts of deamidated peptide could be detected within
an excess of native peptide.
Conditions that allowed separation of native and deami-
dated peptides by micro-HPLC were first established using
p48–61 and p48–61/59D (Fig. 2, a and b). Prior to incuba-
tion, no deamidated peptide was detectable by HPLC or
MS analysis in p48–61 (Fig. 2, a and d). However, after in-
cubating p48–61 for 5 d, a major fraction of the peptide
had become deamidated (Fig. 2, c and f). Kinetic measure-
ments of deamidation over 12 d were done by HPLC and
showed that the conversion proceeds via first order kinetics
(Fig. 2 g). The deamidation occurs rapidly; 
 
 
 
10% of the
peptide becomes deamidated after just 24 h of incubation at
37
 
 
 
C.
 
Type-B Cells Do Not Recognize APCs Pulsed with Native
HEL
 
48–62
 
 Peptide.
 
The finding that p48–61 rapidly con-
verted to a deamidated form at 37
 
 
 
C led us to speculate
Figure 1. Type-B cells preferentially respond to deamidated peptide. T cell responses of (a) a type-A hybridoma (3A9) and (b and c) two type-B hy-
bridomas (ALV-48 and DAV-21) were measured using IL-2 secretion detected by the europium-based DELFIA® assay. HEL ( ), p48–61 ( ), p48–61/
D59 ( ), and p48–61/isoD59 ( ) were added to C3.F6 B cell lymphoma cells at the concentrations indicated and remained in the assay for the duration
of the experiment. DAV-21 was also tested for recognition of p48–62 ( ) and p48–62/59D ( ). CBA spleen cells were also used as APCs in other ex-
periments and gave comparable results. 
1242
 
Deamidation and T Cell Recognition of Hen Egg Lysozyme 48–62
 
that type-B cells could be responding to deamidated pep-
tide created during the assay rather than to native peptide.
To investigate this, we performed experiments where
APCs were pulsed with antigen for 1 h and then washed to
remove excess peptide that either had not been internalized
by the APC or bound to I-A
 
k
 
 at the cell surface. Using this
approach, the response pattern of 3A9 was identical to that
made when antigen was left in the assay (i.e., strong re-
sponses to HEL and the native peptide but no response to
the modified peptides; Fig. 3 a). In contrast, the type-B hy-
bridoma reactivity to the native peptide that was left in the
assay was lost when APCs were pulsed, while the strong re-
sponses to the peptides containing aspartate at residue 59
were maintained (Fig. 3, b and c). These results indicate
not only that the type-B cells do not recognize the native
peptide but also that, once bound to I-A
 
k
 
 or internalized,
p48–62 is inhibited from further spontaneous deamidation.
 
Type-B Cells Recognize Endogenously Processed HEL Pep-
tide.
 
The lack of recognition by type-B T cells of APCs
fed whole HEL antigen, APCs engineered to express full
length HEL, or APCs that express HEL
 
48–62
 
 covalently
linked to I-A
 
k 
 
was thought to indicate that type-B cells
Figure 2. Rapid and spontaneous deamidation of p48–61.
To determine possible deamidation within asparagine residues
under physiological conditions, p48–61 and p48–61/D59
peptides were incubated for different time periods at 37 C in
PBS, pH 7.5, and then analyzed by micro-HPLC-FT-ICR-
MS. HPLC profiles are shown on the left with the corre-
sponding MS contour plot on the right for freshly resus-
pended HEL48–61 (a and d), freshly resuspended p48–61 and
p48–61/D59 in equimolar mix (b and e), and p48–61 after
5-d incubation (c and f). The elution times for p48–61 and
p48–61/D59 were identified using synthetic peptides and are
indicated with dashed lines marked “n” and “d,” respectively.
The signals on the contour plots are also marked with “n” and
“d” to indicate the HPLC peak from which they were de-
rived. Panel g shows the kinetics of the deamidation by plot-
ting the percentage of deamidated peptide over nondeami-
dated peptide calculated by integrating the area under the
respective peaks in the HPLC trace.
Figure 3. Type-B T cell hybridomas do not respond to APCs pulsed with HEL48–61 peptide. T cell responses of (a) a type-A hybridoma (3A9) and (b
and c) two type-B hybridomas (ALV-48 and DAV-21) were measured as in Fig. 1. The assays were performed in a manner identical to that of Fig. 1, ex-
cept CBA splenocytes were used as APCs and antigen was washed from the APCs after a 1-h pulse and before the addition of T cells. Symbols identical
to those in Fig. 1 are used. 
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could not recognize endogenously processed peptide (2).
To investigate this further, we exploited a novel antigen
delivery system using a recombinant antibody specific for
IgD that has been engineered to express the HEL
 
46–61
 
 or
the HEL
 
46–61/59D
 
 sequence in a loop inserted into the C
 
H
 
1
domain (unpublished data). This type of antibody express-
ing another T cell epitope (91–101
 
 
 
2
 
315
 
) has been shown
to be internalized by splenic B cells and subsequently pro-
cessed and efficiently presented to T cells (17). Recogni-
tion by 3A9 of fresh splenocytes from CBA mice that have
been pulsed with the purified 
 
 
 
IgD–IgG3
 
HEL46–61
 
 antibody
confirmed the efficiency (an enhancement of between
1,000 and 10,000 times, compared with the synthetic pep-
tide) of this delivery strategy (Fig. 4 a). Notably, when
splenocytes from B10.BR mice were used as APCs, the re-
sponse to 
 
 
 
IgD–IgG3
 
HEL46–61
 
 was almost abolished, while
the response to the HEL
 
48–61
 
 peptide was unaltered.
B10.BR and CBA mice share identical H-2 haplotypes but
differ in their IgD allotype, with the ‘a’ allotype on the
CBA splenocytes being recognized by the IgD
 
a
 
-specific an-
tibody, while the ‘b’ allotype on the B10.BR B cells is not.
The requirement for IgD
 
a
 
 expression on the splenocytes
strongly suggests that intact antibody has to be internalized
by receptor-mediated endocytosis and that recognition is
not caused by the presentation of peptide that could result
from extracellular degradation of the 
 
 
 
IgD–IgG3
 
HEL46–61
 
antibody. Consistent with this, CBA and B10.BR spleno-
cytes presented nontargeted (anti-NIP) recombinant anti-
bodies containing the HEL epitope equally poorly (data not
shown). Splenocytes pulsed with either the HEL
 
48–61/59D
peptide or  IgD–IgG3HEL46–61/59D antibody failed to stimu-
late this type-A hybridoma as would be expected.
ALV-48 exhibited an extremely vigorous response to the
 IgD–IgG3HEL46–61/59D antibody when pulsed onto APCs
expressing the IgDa allotype (Fig. 4 c), but only a weak re-
sponse was observed when the same antibody was pulsed
onto APCs expressing the IgDb allotype (Fig. 4 d). These
data clearly demonstrate that type-B T cells can readily re-
spond to intracellularly processed antigen and are not lim-
ited to recognizing peptides loaded onto MHC molecules at
the cell surface. DAV-21 did not respond to  IgD–IgG3HEL
antibody, which was to be expected given the dependence
of this hybridoma on the COOH-terminal tryptophan in
p48–62. The antibody contains the shorter HEL46–61 se-
quence, which in the immunoglobulin is followed by a
threonine. DAV-21 responds only weakly to the synthetic
peptide containing a threonine at the residue equivalent to
62 (data not shown), a finding that supports this explanation.
Interestingly, ALV-48 also gave a weak but significant
response to  IgD–IgG3HEL46–61 when presented by CBA
splenocytes. This is likely due to the presence of a minor
fraction of the antibody that has become deamidated dur-
ing production and purification. The HEL sequences re-
place a four–amino acid loop connecting  -strands. This
loop is exposed and surface accessible in the IgG molecule
(20), and the amino acid sequence in the loop varies among
IgGs (21). Furthermore, no interactions have been reported
to exist between loop amino acids and their supporting
framework (20), which suggests to us that the loop may
well be flexible and probably not subject to strong second-
ary structure that could inhibit its deamidation.
T Cell Recognition of HEL48–61 Is Strongly Influenced by
Antigen Structure. The response of ALV-48 to  IgD–
IgG3HEL46–61 indicates that deamidation of the HEL epitope
Figure 4. Type-B hybrid-
omas recognize endogenously
processed peptide. IL-2 secretion
by (a and b) 3A9 and (c and d)
ALV-48 in response to spleno-
cytes pulsed for 1 h with whole
lysozyme ( ), p48–61 ( ), p48–
61/D59 ( ), recombinant
 IgD–IgG3HEL46–61 (  ), or re-
combinant  IgD–IgG3HEL46–61/59D
( ) were detected by a eu-
ropium-based DELFIA® assay.1244 Deamidation and T Cell Recognition of Hen Egg Lysozyme 48–62
is possible when it is within the structural context of the
antibody, but not within intact HEL. To further probe
what influence structure may have on deamidation of this
peptide, we compared the stimulation of 3A9 and ALV-48
by HEL48–61 peptide, fresh  IgD–IgG3HEL supernatant, and
whole HEL, with or without preincubating these antigens
in PBS at 37 C for 16 h (Fig. 5, a and b). After a 1-h pulse
onto splenocytes, all three antigens strongly stimulated 3A9
regardless of whether they had been preincubated or not
(Fig. 5 a). Results were different with the ALV-48 hybrid-
oma: free peptide and  IgD–IgG3HEL were only able to
stimulate ALV-48 if they had undergone a period of prein-
cubation at 37 C. HEL was not stimulatory under any cir-
cumstances (Fig. 5 b). These results illustrate that the struc-
tural context of epitope within an antigen can have a
radical effect on its recognition by T cells. In addition, they
provide further evidence that the response toward the na-
tive peptide by the type-B hybridomas is due to the spon-
taneous deamidation during the course of the assay.
Discussion
We have shown that T cells raised against an immuno-
dominant peptide from HEL can be divided into those T
cells that recognize the native peptide and whole lysozyme
antigen (type-A) and those that recognize the deamidated
peptide (type-B). Biochemical studies aimed at determining
which residues are prone to deamidation within intact pro-
teins are difficult and can be misleading, as residues may
deamidate during the identification procedure rather than
in the intact protein. Nevertheless, studies of intact HEL
have found no evidence that the asparagine at position 59 is
deamidated, although deamidation of other asparagine resi-
dues has been identified (10, 14, 15). The Asn-59 is posi-
tioned close to the active site of lysozyme, and the highly
ordered structure within this region is likely to be responsi-
ble for this lack of deamidation and consequent failure of
the type-B cells to recognize whole antigen. The T cell hy-
bridomas used in this study are the archetypal type-B T
cells that display no significant responses to HEL, and as
demonstrated here, they possess little or no cross-reactivity
between the asparagine- and aspartate-containing peptides.
Clearly, other T cells that demonstrate more cross-reactiv-
ity would be expected to display a less pronounced type-B
phenotype. Notably, Mamula et al. have generated specific
T cell responses to murine cytochrome C and snRNP
d-isoaspartate-containing peptides by vaccination with
synthetic modified peptides (22). As we observed that the
ALV-48 hybridomas cross-reacted with the isoaspartate-
containing peptide, this indicates that this peptide can bind
to I-Ak and could conceivably be recognized by other
type-B hybridomas.
Studies of type-B T cell recognition of the HEL48–62
epitope have provided some persuasive evidence support-
ing the idea that a peptide can bind to MHC molecules in
more than one distinct and stable conformation. In an ele-
gant experiment, Viner et al. (1) purified I-Ak from APCs
fed HEL that by definition were not recognized by type-B
hybridomas. When peptides were eluted from these I-Ak
molecules and then added back to APCs, the eluted pep-
tides were found to stimulate the type-B T cells. The au-
thors reasoned that this was due to the binding of the pep-
tide to I-Ak at the cell surface rather than through an
endogenous route (2). However, this can now be explained
by the spontaneous deamidation of the eluted peptide after
its release from the binding cleft of I-Ak, where deamida-
tion is inhibited. Thus, our data strongly argues against the
existence of different stable peptide–MHC conformations
Figure 5. T cell recognition of antigens preincubated at 37 C. HEL, p48–61, and fresh  IgD–IgG3HEL46–61 antibody supernatant was tested for T cell
hybridoma recognition by (a) 3A9 or (b) ALV-48, either freshly prepared or after incubation at 37 C for 16 h (marked with *). Both the fresh antigen and
the preincubated antigen were pulsed onto CBA splenocytes for 1 h before washing and the addition of T cells. HEL and p48–61 were tested at 10  M,
whereas the concentration of  IgD–IgG3HEL was 1  M. IL-2 released into the assay was then detected using the europium DELFIA® assay.1245 McAdam et al.
and suggests that when T cell recognition of peptide and
whole antigen is discordant, then this phenomenon more
likely could be explained by a posttranslational modifica-
tion of peptide or antigen.
Expression of HEL as a transgenic self-protein in mice
has been shown to result in a profound T cell tolerance to a
subsequent challenge with this antigen (23). Notably,
Peterson et al. have demonstrated that type-B T cells spe-
cific for the HEL48–62 peptide can escape this negative selec-
tion (2). Based on our results, the failure in negative selec-
tion and peripheral tolerance can be explained by a lack of
presentation of deamidated peptide, both in the thymus and
in the periphery. Interestingly, it could be envisaged that
during periods of tissue injury or stress, or after abnormal
antigen expression or clearance, antigen may be released in
a manner that would allow deamidation to occur. Thus, the
creation of deamidated peptides may be concomitant with a
local milieu that is likely to contain activated APCs, a situa-
tion likely to initiate and propagate a T cell response to the
modified peptide and possibly lead to autoimmunity.
The generation of T cell responses to posttranslationally
modified peptides is of particular relevance when designing
peptide- and recombinance-based vaccines, where a re-
sponse to unmodified antigen is likely to be desirable. Our
data illustrates that a potential danger of using such artificial
antigens is that asparagine(s) that are stable in the native an-
tigen could be converted into a labile one, and hence a T
cell response could be generated to a modified epitope that
did not cross-react with the unmodified sequence. More-
over, responses to the synthetic or recombinant peptides in
vitro could be erroneously interpreted as an ability of the
induced T cells to recognize unmodified antigen. This ar-
gument might be of special relevance to cancer vaccines
(24) and warrants caution in interpretation of results ob-
tained with synthetic tumor-specific peptides or recombi-
nant antigens. Our study provides a conceptual framework
for understanding how and why type-B T cells can be gen-
erated and will allow identification of peptides that are
prone to these types of modification.
We have demonstrated that posttranslational modifica-
tion plays a major role in the recognition of one of the
most intensively studied T cell epitopes in immunology,
and this finding underscores the difficulty of characterizing
T cells specific for posttranslationally modified epitopes.
The frequency and biological importance of posttransla-
tionally modified T cell epitopes in immunology may well
be underappreciated.
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